1 unknown. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
Follow anti-ILT3 CAR-T: new trials by email Literature Review of anti-ILT3 CAR-T trials Research Report on anti-ILT3 CAR-T
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5) anti-ILT3 CAR-T - AML M4, AML M5 | Early Phase 1 | Unknown | Carbiogene Therapeutics Co. Ltd. | 25 | 2021-03-03 | 2021-03-23 |
Leukemia, Monocytic, Acute (1) · Leukemia, Myelomonocytic, Acute (1)
Carbiogene Therapeutics Co. Ltd. (1)
China (1)
Jianping Lan (1)